Literature DB >> 10658906

Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.

R Vang1, L J Medeiros, C S Ha, M Deavers.   

Abstract

Non-Hodgkin's lymphomas (NHL) involving the uterus may be either low-stage neoplasms that probably arise in the uterus (primary) or systemic neoplasms with secondary involvement. In this study, 26 NHL involving the uterus are reported. Ten cases were stage I(E) or II(E) and are presumed to be primary. The mean age of patients at presentation was 55 years (range, 35 to 67 years), and abnormal uterine bleeding was the most frequent complaint (six patients). Nine of 10 tumors involved the cervix. Histologically, eight were diffuse large B-cell lymphoma (DLBCL); one was follicle center lymphoma, follicular, grade 1; and one was marginal zone B-cell lymphoma. At 5 years of clinical follow-up, five of six patients were alive after treatment. In 12 cases, uterine involvement was part of a systemic disease at diagnosis, either stage III(E) or IV. The mean patient age at the time that uterine involvement was detected was 58 years (range, 22 to 75 years); 6 of 12 had abnormal uterine bleeding. Six tumors involved both cervix and corpus, four corpus, and two cervix. Six were DLBCL; two were small lymphocytic lymphoma; three were follicle center lymphoma, follicular, grade 1 (two cases) or grade 2 (one case); and one was precursor T-cell lymphoblastic lymphoma. At 5 years of clinical follow-up, two of seven patients were alive after treatment. Four DLBCL arose in patients with incomplete clinical information; therefore, stage is unknown. We conclude that low-stage (presumably primary) uterine NHL are most commonly DLBCL, predominantly arise in the cervix, and cause abnormal uterine bleeding. High-stage NHL are a heterogeneous group of B-cell neoplasms that can involve the cervix or the corpus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658906     DOI: 10.1038/modpathol.3880005

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  23 in total

1.  Primary Non-Hodgkin's Lymphoma of Diffuse Large B-Cell Phenotype [DLBCL] of Uterine Corpus: A Rare Case Report with Brief Review of the Literature.

Authors:  Manoj Kumar Patro; Atanu Kumar Bal; T Santosh; Bandana Mishra
Journal:  J Obstet Gynaecol India       Date:  2016-04-16

Review 2.  Synchronous diffuse large B cell lymphomas of the endometrium and breast: a staging dilemma.

Authors:  J P Gleeson; G B Woods; G A Watson; J Ryan; E Doyle; F Quinn; J C O'Keane; J A McCaffrey
Journal:  Ir J Med Sci       Date:  2017-05-03       Impact factor: 1.568

3.  Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.

Authors:  Abner Louissaint; Kristian T Schafernak; Julia T Geyer; Alexandra E Kovach; Mahmoud Ghandi; Dita Gratzinger; Christine G Roth; Christian N Paxton; Sunhee Kim; Chungdak Namgyal; Ryan Morin; Elizabeth A Morgan; Donna S Neuberg; Sarah T South; Marian H Harris; Robert P Hasserjian; Ephraim P Hochberg; Levi A Garraway; Nancy Lee Harris; David M Weinstock
Journal:  Blood       Date:  2016-06-20       Impact factor: 22.113

Review 4.  Diffuse large B-cell lymphoma of the uterus suspected of having transformed from a marginal zone B-cell lymphoma harboring trisomy 18: a case report and review of the literature.

Authors:  Kei-Ji Sugimoto; Hidenori Imai; Asami Shimada; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Noriko Nakamura; Tomohiro Sawada; Hiroshi Izumi; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

5.  Primary malignant lymphoma of the uterine cervix.

Authors:  Fariba Binesh; Mojgan Karimi zarchi; Hasanali Vahedian; Yavar Rajabzadeh
Journal:  BMJ Case Rep       Date:  2012-09-24

6.  Uterine sarcomas in Port Harcourt, Nigeria: a 12-year clinico-pathologic study.

Authors:  D Seleye-Fubara; S A Uzoigwe
Journal:  Afr Health Sci       Date:  2007-03       Impact factor: 0.927

7.  Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.

Authors:  Barbara C Rütgen; Saskia Willenbrock; Nicola Reimann-Berg; Ingrid Walter; Andrea Fuchs-Baumgartinger; Siegfried Wagner; Boris Kovacic; Sabine E Essler; Ilse Schwendenwein; Ingo Nolte; Armin Saalmüller; Hugo Murua Escobar
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

8.  Unusual involvement of cervix and vulva in a case of chronic lymphocytic leukemia.

Authors:  Karthik Udupa; Prasanth Ganesan; Urmila Majhi; Tenali Gnana Sagar
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

Review 9.  Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Authors:  E Campo; A Chott; M C Kinney; L Leoncini; C J L M Meijer; C S Papadimitriou; M A Piris; H Stein; S H Swerdlow
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

10.  Lymphoma of the cervix.

Authors:  Juanita Parnis; David J Camilleri; Darko Babic; James Degaetano; Charles Savona-Ventura
Journal:  Case Rep Hematol       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.